Zuora Inc (NYSE:ZUO) SVP Jennifer Pileggi sold 10,000 shares of Zuora stock in a transaction on Monday, July 8th. The shares were sold at an average price of $16.02, for a total value of $160,200.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Jennifer Pileggi also recently made the following trade(s):
- On Wednesday, June 19th, Jennifer Pileggi sold 10,000 shares of Zuora stock. The shares were sold at an average price of $16.01, for a total value of $160,100.00.
Shares of Zuora stock opened at $16.35 on Friday. Zuora Inc has a twelve month low of $13.04 and a twelve month high of $35.68. The firm has a market capitalization of $1.78 billion, a PE ratio of -19.94 and a beta of 1.97. The company has a quick ratio of 1.91, a current ratio of 1.91 and a debt-to-equity ratio of 0.05. The firm has a fifty day moving average price of $16.10.
A number of institutional investors have recently modified their holdings of ZUO. FMR LLC acquired a new position in Zuora in the fourth quarter valued at $73,320,000. Carmignac Gestion acquired a new position in Zuora in the fourth quarter valued at $30,553,000. Gilder Gagnon Howe & Co. LLC boosted its holdings in Zuora by 198.2% in the first quarter. Gilder Gagnon Howe & Co. LLC now owns 1,975,935 shares of the company’s stock valued at $39,578,000 after acquiring an additional 1,313,273 shares during the last quarter. Brown Advisory Inc. boosted its holdings in Zuora by 1,944.0% in the fourth quarter. Brown Advisory Inc. now owns 1,328,270 shares of the company’s stock valued at $24,095,000 after acquiring an additional 1,263,285 shares during the last quarter. Finally, Baillie Gifford & Co. acquired a new position in Zuora in the first quarter valued at $21,556,000. Hedge funds and other institutional investors own 37.64% of the company’s stock.
A number of equities research analysts have recently commented on the company. Jefferies Financial Group lowered their price objective on Zuora from $35.00 to $29.00 and set a “buy” rating for the company in a research report on Friday, May 31st. Needham & Company LLC reaffirmed a “buy” rating and issued a $137.00 price objective (up previously from $105.00) on shares of Okta in a research report on Friday, May 31st. Morgan Stanley lowered their price objective on Zuora from $22.00 to $16.00 and set an “equal weight” rating for the company in a research report on Friday, May 31st. Canaccord Genuity reaffirmed a “hold” rating on shares of National Bank of Canada in a research report on Friday, May 31st. Finally, Zacks Investment Research downgraded Zynerba Pharmaceuticals from a “buy” rating to a “hold” rating in a research report on Saturday, June 8th. One analyst has rated the stock with a sell rating, two have given a hold rating and five have assigned a buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $19.43.
Zuora Company Profile
Zuora, Inc provides cloud-based software on a subscription basis that enables companies in various industries to launch, manage, and transform into a subscription business. The company offers Zuora Central platform that acts as an intelligent subscription management hub that automates the subscription order-to-cash process, including quoting, billing, collections, analytics, and revenue recognition.
Recommended Story: What is a conference call?
Receive News & Ratings for Zuora Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zuora and related companies with MarketBeat.com's FREE daily email newsletter.